News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,152 Results
Type
Article (59382)
Company Profile (168)
Press Release (656592)
Multimedia
Podcasts (126)
Webinars (22)
Section
Business (190273)
Career Advice (2802)
Deals (34711)
Drug Delivery (128)
Drug Development (79052)
Employer Resources (164)
FDA (16231)
Job Trends (14964)
News (328608)
Policy (31291)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2801)
Academic (2)
Accelerated approval (35)
Adcomms (30)
Allergies (154)
Alliances (49407)
ALS (175)
Alzheimer's disease (1642)
Antibody-drug conjugate (ADC) (317)
Approvals (16515)
Artificial intelligence (594)
Autoimmune disease (170)
Automation (44)
Bankruptcy (317)
Best Places to Work (11668)
BIOSECURE Act (21)
Biosimilars (187)
Biotechnology (113)
Bladder cancer (161)
Brain cancer (63)
Breast cancer (641)
Cancer (4924)
Cardiovascular disease (404)
Career advice (2398)
Career pathing (40)
CAR-T (301)
CDC (48)
Celiac Disease (2)
Cell therapy (800)
Cervical cancer (38)
Clinical research (67566)
Collaboration (1798)
Company closure (5)
Compensation (816)
Complete response letters (60)
COVID-19 (2751)
CRISPR (102)
C-suite (932)
Cystic fibrosis (147)
Data (6330)
Decentralized trials (1)
Denatured (49)
Depression (142)
Diabetes (485)
Diagnostics (6967)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (279)
Drug pricing (192)
Drug shortages (28)
Duchenne muscular dystrophy (223)
Earnings (71833)
Editorial (62)
Employer branding (19)
Employer resources (145)
Events (110594)
Executive appointments (1048)
FDA (19485)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1538)
Gene editing (217)
Generative AI (56)
Gene therapy (606)
GLP-1 (941)
Government (4854)
Grass and pollen (8)
Guidances (384)
Healthcare (19215)
HIV (61)
Huntington's disease (41)
IgA nephropathy (77)
Immunology and inflammation (239)
Immuno-oncology (62)
Indications (122)
Infectious disease (3032)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (123)
Intellectual property (259)
Interviews (531)
IPO (15908)
IRA (48)
Job creations (3659)
Job search strategy (1986)
JPM (66)
Kidney cancer (18)
Labor market (80)
Layoffs (601)
Leadership (37)
Legal (7113)
Liver cancer (89)
Longevity (17)
Lung cancer (652)
Lymphoma (373)
Machine learning (44)
Management (57)
Manufacturing (815)
MASH (168)
Medical device (14445)
Medtech (14507)
Mergers & acquisitions (19928)
Metabolic disorders (1250)
mRNA (186)
Multiple sclerosis (158)
NASH (16)
Neurodegenerative disease (315)
Neuropsychiatric disorders (91)
Neuroscience (2890)
Neurotech (1)
NextGen: Class of 2026 (6743)
Non-profit (4512)
Now hiring (33)
Obesity (570)
Opinion (316)
Ovarian cancer (167)
Pain (208)
Pancreatic cancer (235)
Parkinson's disease (280)
Partnered (35)
Patents (524)
Patient recruitment (528)
Peanut (62)
People (62308)
Pharmaceutical (33)
Pharmacy benefit managers (27)
Phase 1 (21468)
Phase 2 (29838)
Phase 3 (21698)
Pipeline (5546)
Policy (297)
Postmarket research (2406)
Preclinical (9181)
Press Release (69)
Prostate cancer (255)
Psychedelics (44)
Radiopharmaceuticals (301)
Rare diseases (860)
Real estate (6369)
Recruiting (69)
Regulatory (23888)
Reports (41)
Research institute (2605)
Resumes & cover letters (418)
Rett syndrome (28)
RNA editing (16)
RSV (76)
Schizophrenia (149)
Series A (264)
Series B (196)
Service/supplier (11)
Sickle cell disease (97)
Special edition (16)
Spinal muscular atrophy (157)
Sponsored (44)
Startups (3709)
State (2)
Stomach cancer (12)
Supply chain (92)
Tariffs (73)
The Weekly (75)
Vaccines (1038)
Venture capital (84)
Weight loss (353)
Women's health (89)
Worklife (22)
Date
Today (174)
Last 7 days (700)
Last 30 days (2562)
Last 365 days (29713)
2026 (4356)
2025 (29947)
2024 (34227)
2023 (38842)
2022 (49853)
2021 (54792)
2020 (53683)
2019 (47496)
2018 (36152)
2017 (32795)
2016 (32338)
2015 (38021)
2014 (30835)
2013 (26992)
2012 (28597)
2011 (28857)
2010 (27177)
Location
Africa (927)
Alabama (89)
Alaska (7)
Arizona (276)
Arkansas (14)
Asia (42410)
Australia (7574)
California (10909)
Canada (3234)
China (1111)
Colorado (473)
Connecticut (481)
Delaware (347)
Europe (97244)
Florida (1674)
Georgia (368)
Hawaii (3)
Idaho (62)
Illinois (909)
India (72)
Indiana (512)
Iowa (20)
Japan (441)
Kansas (130)
Kentucky (42)
Louisiana (27)
Maine (75)
Maryland (1375)
Massachusetts (7872)
Michigan (354)
Minnesota (648)
Mississippi (6)
Missouri (141)
Montana (36)
Nebraska (25)
Nevada (123)
New Hampshire (88)
New Jersey (3041)
New Mexico (31)
New York (2967)
North Carolina (1446)
North Dakota (9)
Northern California (5297)
Ohio (337)
Oklahoma (23)
Oregon (43)
Pennsylvania (2187)
Puerto Rico (24)
Rhode Island (43)
South America (1252)
South Carolina (70)
South Dakota (1)
Southern California (4301)
Tennessee (174)
Texas (1744)
United States (39565)
Utah (341)
Vermont (1)
Virginia (264)
Washington D.C. (73)
Washington State (924)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
716,152 Results for "institute of microbial technology imtech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
CD Genomics Launches Microbial Single-Cell Sequencing Service, Emerging as One of the Few Providers Capable of Unlocking “Microbial Dark Matter”
February 2, 2026
·
1 min read
Press Releases
Mitsubishi Electric and Indian Institute of Technology Hyderabad Sign MOU to Strengthen Industry-Academia Collaboration
February 12, 2026
·
1 min read
Sponsored
WHITE PAPER: Optimized extraction solutions for the recovery of high-quality microbial nucleic acids from vaginal samples
The OMNIgene™•XTRACT ULTRA kit enables the optimal recovery of large quantities of high-quality DNA and RNA from a wide range of sample types including vaginal samples collected with the OMNIgene™•VAGINAL device. The OMNIgene™•XTRACT ULTRA kit is the first solution validated to provide significantly higher DNA and RNA yields from vaginal samples to better support multi-omic analysis of microbial communities.
December 4, 2025
·
1 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
January 28, 2026
·
5 min read
Press Releases
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
January 13, 2026
·
7 min read
Press Releases
Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy
July 31, 2025
·
7 min read
Press Releases
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
December 11, 2025
·
9 min read
Cell therapy
After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.
January 21, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies
February 5, 2026
·
7 min read
1 of 71,616
Next
